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Background: The absorption of dietary long chain fatty acids (LCFA) largely occurs in the jejunum. LCFA are
activated via conjugation with Coenzyme A (CoA), a reaction catalyzed by Acyl-CoA synthetases (ACS). Acyl-CoA
sythesis is critical for dietary LCFA absorption; yet, the jejunal ACS enzymes that catalyze the reaction are largely
unknown.
Findings: High throughput mRNA sequencing of the mouse jejunum revealed that the expression of acyl-CoA
synthetase 5 (Acsl5) and fatty-acid transport protein 4 (Fatp4) largely exceeded all other annotated ACS genes that
activate LCFA. Interestingly, Acsl5 knockout (KO) mice displayed a decrease of 60% in jejunal total long chain
acyl-CoA synthesis rate. Nevertheless, and despite of this decrease, dietary LCFA absorption and body-weight gain
in response to high fat diet remained unaffected.
Conclusion: Acsl5 is a major activator of dietary LCFA, yet in Acsl5 KO mice residual ACS activity is sufficient for
maintaining a normal LCFA absorption. Our findings provide further evidence for a robust small intestine LCFA
absorption capacity.
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Background
Intestinal absorption of dietary long chain fatty acids
(LCFA) is an important determinant of body weight
and obesity-related metabolic disorders. LCFA absorp-
tion largely occurs in the jejunum where these
nutrients undergo uptake across the brush border
membrane of enterocytes. LCFA uptake is followed by
a critical activation step through conjugation with
coenzyme-A (CoA). In enterocytes, dietary LCFA-CoA
conjugates are primarily utilized for triglycerides (TG)
synthesis, packed into chylomicrons and secreted
through the basolateral membrane [1,2]. LCFA conju-
gation with CoA is catalyzed by Acyl-CoA synthetases
(ACS). Mammals possess 13 annotated ACS genes that
activate LCFA and clustered in three different gene
families: ACSL (acyl-CoA synthetase long chain),* Correspondence: sehayee@ccf.org
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reproduction in any medium, provided the orACSBG (acyl-CoA synthetase bubblegum) and FATP
(fatty acid transport proteins; also designated ACSVL
or SLC27) [3-5]. The impact of each of these genes on
intestinal absorption of LCFA is largely unknown.
Methods
The methods used are described briefly at the figure
legends. Detailed description of mice, diets and assays
used in the study is presented in Additional files 1 and
2. All experiments involving mice were approved by the
Cleveland Clinic Animal Care and Use Committee.
Results
Expression of long chain acyl-CoA synthetase genes in
C57BL/6J jejunum was determined by transcriptome
shotgun sequencing analysis (mRNA-seq). As shown in
Figure 1, out of the 13 annotated LCFA acyl-CoA
synthetase genes, the number of properly paired reads
that were aligned to Acsl5 and Fatp4 largely exceeded
the number of reads that were aligned to the other
genes. A previous study has shown that Fatp4 istd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and


























































Figure 1 Acsl5 and Fatp4 are the two predominant LCFA
CoA-synthetases in mouse jejunum. Five C57BL/6J females were
fasted for 6 hours, sacrificed, the jejunum harvested, polyadenylated
RNA isolated, cDNA synthesized and sequenced. Sequencing reads
were aligned against a reference mouse genome. Gene expression
levels were calculated as mean±SD of properly paired (PP)-end reads
aligned to each gene after normalization for mRNA length in












































































Figure 2 Reduced total jejunal ACS activity in Acsl5 KO mice. Jejunal m
(WT), heterozygous (Het) or knockout (KO) mice, 5 animals per group, were
incubated in the presence of raiolabeled palmitic acid, ATP and CoA. Unco
radioactivity, containing the water soluble palmitoyl-CoA was determined b
are presented.
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focused our efforts on elucidating the role of Acsl5.
Quantitative PCR and Western blotting demonstrated
that Acsl5 is preferentially expressed in the jejunum
(Additional file 3). These results suggested a role for
Acsl5 in determining the jejunal absorption of LCFA.
To determine the role of Acsl5 in jejunal LCFA-CoA
synthesis and absorption, we have used mice that were
targeted for this gene (characterization of targeted ani-
mals is found in Additional file 2). Jejunum mucosal ho-
mogenates were assayed for acyl-CoA synthesis rate by
using palmitic acid, a prototype member of the long
chain fatty acid family, as a substrate. As shown in
Figure 2A, as compared to wild-type littermate controls,
Acsl5-KO males and females displayed a decrease of
60% in jejunal palmitoyl-CoA synthesis rate. Animals
heterozygous for the targeted allele displayed only a
moderate 15-35% decrease in activity, which reached
statistical significance only in females. When compared
to the jejunum, liver Acsl5 expression is diminished
(Additional file 3). Consistent with these findings, liver
synthesis rates of palmitoyl-CoA in Acsl5 KO mice were
fully conserved (Figure 2B).
To determine the effect of Acsl5 targeting on LCFA
absorption, mice were fasted overnight, lipases activity
inhibited through intravenous injection of tyloxapol, ani-
mals provided with a gastric bolus of olive oil supple-





































































ucosa (A) and liver tissues (B) from female or male Acsl5 wild type
harvested and homogenized. Equal amounts of protein were
njugated fatty acid was extracted in heptane and aqueous phase
y scintillation counting. Mean±SD palmitoyl-CoA synthesis rates
Figure 3 Acsl5 KO mice display a normal dietary LCFA absorption from the intestine. Acsl5 WT and KO mice, females or males,
(5 per group), were fasted overnight and than intravenously injected with tyloxapol to inhibit vascular lipases. Thirty minutes later the mice
received a gastric bolus olive oil supplemented with radiolabeled oleic acid and retroorbital sinus blood samples were collected at 30, 60
and 90 min post gavage. Plasma radioactivity was determined by scintillation counting.
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collected for the first 90 minutes post gastric gavage. As
shown in Figure 3, as compared to littermate wild-type
controls, Acsl5-KO males and females displayed undistin-
guishable plasma accumulation of the radiolabeled tracer.
These finding suggested that targeting of the Acsl5 gene
has no impact on intestinal LCFA absorption.
To determine the effect of Acsl5 targeting on body-
weight gain in response to high fat diet, mice were fed a
Western-type diet for 13 weeks. As shown in Figure 4,
Acsl5-KO males and females displayed weight gain that
was indistinguishable of their littermate wild-type con-
trols. Finally, targeting of Acsl5 had no effect on dietary
cholesterol absorption, plasma cholesterol levels, plasma
triglycerides or fasting plasma glucose levels (data not
shown).
Discussion
We identified Acsl5 as a major ACS gene expressed in the
jejunum (Figure 1). Interestingly, while Acsl5 targeting
resulted in a substantial decrease in jejunal total LCFA
ACS activity (Figure 2) this decrease was not sufficient to
reduce either LCFA absorption or body weight gain in re-
sponse to high fat diet (Figures 3 and 4). As expression
levels of other ACS genes in the jejunum remained stableFEMALES





















Figure 4 Acsl5 KO display normal weight gain in response to high fat
fed a Western type diet for 13 weeks and body weights were recorded. No
WT animals.(Additional file 2), these findings are consistent with a
large capacity of the small intestine to absorb dietary
LCFA. Therefore, even a reduction of 60% in total ACS
activity is insufficient in affecting the absorption of LCFA
even under conditions where the absorption process is
stressed by the feeding of a high fat diet.
Our mRNA-Seq results suggest that jejunum Acsl5 and
Fatp4 are expressed at a comparable level and together ac-
count for over 90% of the LCFA ACS transcripts in this
tissue (Figure 1). A previous study reported, through
targeting of Fatp4, that this enzyme is dispensable for in-
testinal fat absorption [6]. Unfortunately the authors have
not reported the effect of Fatp4 targeting on jejunal
LCFA-CoA synthesis rate. Interestingly, studies in newly
born Fatp4-KO mice demonstrated ~10 fold inhibition in
activation of the very long FA lignoceric acid (C24:0) but
no inhibition of the LCFA palmitic or oleic acids [7].
These findings may suggest that Fatp4 is not a major
determinant of LCFA absorption from the intestine.
Nevertheless, studies in Acsl5/intestinal-Fatp4 double
KO, that are beyond the scope of this report, are
needed to clarify the combined effect of Acsl5 and
Fatp4. It is of note that Fatp2, amongst the three
highly-expressed LCFA ACS gene in the jejunum
(Figure 1), may also contribute to LCFA absorptionMALES






















diet. Acsl5 WT and KO mice, females or males, (5 per group), were
significant differences are observed between Acsl5 KO and
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nally, we cannot exclude the possibility that additional,
not as yet identified, ACS genes may contribute to ab-
sence of phenotype in Acsl5 knockouts.
Additional files
Additional file 1: Methods. Jejunum mRNA sequencing and analysis.
Quantitative PCR. Western blotting Analysis. Total acyl-CoA synthesis
assay. Dietary LCFA absorption assay. Statistical analysis.
Additional file 2: Acsl5 KO mice. Animals and diets description. Acsl5
protein expression in WT, Heterozygote and KO mice. qPCR analysis of
expression of major ACS genes and genes involved in fat absorption in
Acsl5 KO and WT mice jejunum.
Additional file 3: Acsl5 is preferentially expressed in the jejunum.
RNA and protein levels of Acsl1 and Acsl5 in tissues with active fatty acid
metabolism and along the longitudinal axis of the gastrointestinal tract.
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